Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Beow Yong Yeap, Sc.D.

Concepts (713)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Beow Yeap's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Beow Yeap has written about over time.
Quinazolines, 17 publications between 2004 and 2012, average publication date August 2008. Mesothelioma, 21 publications between 2005 and 2021, average publication date April 2011. Pleural Neoplasms, 21 publications between 2005 and 2021, average publication date December 2011. Adenocarcinoma, 19 publications between 2004 and 2022, average publication date February 2012. Neoplasm Recurrence, Local, 25 publications between 1990 and 2022, average publication date April 2012. Carcinoma, Non-Small-Cell Lung, 49 publications between 2004 and 2024, average publication date December 2012. Lung Neoplasms, 65 publications between 2004 and 2024, average publication date May 2013. Protein Kinase Inhibitors, 26 publications between 2005 and 2024, average publication date November 2013. Drug Resistance, Neoplasm, 17 publications between 2006 and 2024, average publication date December 2014. Brain Neoplasms, 18 publications between 2005 and 2024, average publication date May 2015. Photons, 9 publications between 2008 and 2020, average publication date April 2016. Medulloblastoma, 10 publications between 2015 and 2022, average publication date May 2019. Cerebellar Neoplasms, 9 publications between 2015 and 2022, average publication date July 2019.

To see the data from this visualization as text, click here.
Yeap's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (713)
Explore
_
Co-Authors (241)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.